Cullinan Therapeutics annual meeting results: all proposals pass, directors elected

Cullinan Therapeutics, Inc.

Elected Class II directors: Anthony Rosenberg, David P. Ryan, Mary Thistle; each received >47M votes for.
Ratified KPMG as independent auditor for FY2025: 51.9M for, 157K against, 14K abstain.
Approved advisory say-on-pay on executive compensation: 46.96M for, 2.00M against, 14.7K abstain.
Stockholders voted for annual say-on-pay frequency (48.5M for 1 year); board adopts annual vote.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.